{"id":"W2923651250","doi":"10.1093/jnci/djz032","title":"Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer","year":2019,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Yonsei University College of Medicine; University of Florida Health; Cancer Institute, University of Pittsburgh; Weill Cornell Medical College; Peter MacCallum Cancer Centre; Yonsei University; Department of Medicine, Georgetown University; KU Leuven; NRG Oncology; University of Ottawa; Allegheny Health Network; VCU Massey Cancer Center; Virginia Commonwealth University; National Cancer Institute; Kaiser Permanente; Breast Cancer Research Foundation; Pennsylvania Department of Health; AstraZeneca; Georgetown University; Genentech; University of Pittsburgh; Amgen","keywords":"Trastuzumab; Medicine; Internal medicine; Oncology; Breast cancer; Hazard ratio; Confidence interval; Concordance; Stage (stratigraphy); Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001479461,0.0002334967,0.0006430121,0.0002904511,0.0001476181,0.00005559723,0.0004746432,0.0001478172,0.0003758601],"category_scores_gemma":[0.0004934858,0.0001657924,0.0003425921,0.0004703585,0.000204506,0.000463199,0.00009133162,0.0008170161,0.00001104252],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006398987,"about_ca_system_score_gemma":0.01198633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001930583,"about_ca_topic_score_gemma":0.001348263,"domain_scores_codex":[0.9965785,0.0001331144,0.0009020927,0.0002932319,0.001628564,0.0004645538],"domain_scores_gemma":[0.9970447,0.0003424326,0.0007334535,0.0001682073,0.001516243,0.0001949466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3262011,0.00237293,0.4908445,0.001336472,0.00246323,0.0005518423,0.003651523,0.03611554,0.0352479,0.003520631,0.04920832,0.04848591],"study_design_scores_gemma":[0.1962208,0.004331125,0.651139,0.004583799,0.0003594643,0.001429075,0.0005152972,0.00295813,0.01433994,0.0005591898,0.1228095,0.0007546539],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.982999,0.0007349423,0.00002097444,0.006752579,0.004488622,0.001632167,0.0007604744,0.00001088912,0.002600396],"genre_scores_gemma":[0.9919586,0.0002500196,0.0004855839,0.001650256,0.004119626,0.0002039624,0.000007454701,0.00003604383,0.001288492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1602944,"threshold_uncertainty_score":0.9974152,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0748041909655118,"score_gpt":0.427290851404628,"score_spread":0.3524866604391161,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}